In silico experiment system for testing hypothesis on gene functions using three condition specific biological networks.

Determining functions of a gene requires time consuming, expensive biological experiments. Scientists can speed up this experimental process if the literature information and biological networks can be adequately provided. In this paper, we present a web-based information system that can perform in silico experiments of computationally testing hypothesis on the function of a gene. A hypothesis that is specified in English by the user is converted to genes using a literature and knowledge mining system called BEST. Condition-specific TF, miRNA and PPI (protein-protein interaction) networks are automatically generated by projecting gene and miRNA expression data to template networks. Then, an in silico experiment is to test how well the target genes are connected from the knockout gene through the condition-specific networks. The test result visualizes path from the knockout gene to the target genes in the three networks. Statistical and information-theoretic scores are provided on the resulting web page to help scientists either accept or reject the hypothesis being tested. Our web-based system was extensively tested using three data sets, such as E2f1, Lrrk2, and Dicer1 knockout data sets. We were able to re-produce gene functions reported in the original research papers. In addition, we comprehensively tested with all disease names in MalaCards as hypothesis to show the effectiveness of our system. Our in silico experiment system can be very useful in suggesting biological mechanisms which can be further tested in vivo or in vitro. AVAILABILITY http://biohealth.snu.ac.kr/software/insilico/.

[1]  Jusang Lee,et al.  Prioritizing biological pathways by recognizing context in time-series gene expression data , 2016, BMC Bioinformatics.

[2]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[3]  Xin Ma,et al.  KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. , 2017, Cancer research.

[4]  Jaehoon Choi,et al.  BEST: Next-Generation Biomedical Entity Search Tool for Knowledge Discovery from Biomedical Literature , 2016, PloS one.

[5]  Krzysztof Safranow,et al.  E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy , 2016, Pathology & Oncology Research.

[6]  Xing-Ming Zhao,et al.  NARROMI: a noise and redundancy reduction technique improves accuracy of gene regulatory network inference , 2013, Bioinform..

[7]  Maolin Yan,et al.  The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study. , 2017, International journal of biological macromolecules.

[8]  Ivana V. Yang,et al.  The role of the E2F1 transcription factor in the innate immune response to systemic LPS. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[9]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[10]  Kin Tak Chan,et al.  Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance , 2015, Clinical Cancer Research.

[11]  Ying Liu,et al.  Small compound bigelovin exerts inhibitory effects and triggers proteolysis of E2F1 in multiple myeloma cells , 2013, Cancer science.

[12]  Wei-De Zhong,et al.  E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer. , 2016, International journal of oncology.

[13]  P. Venugopal,et al.  Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes. , 2003, Journal of hematotherapy & stem cell research.

[14]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[15]  Jaewoo Kang,et al.  CLIP-GENE: a web service of the condition specific context-laid integrative analysis for gene prioritization in mouse TF knockout experiments , 2016, Biology Direct.

[16]  D. Latchman.  Transcription factors: an overview. , 1997, The international journal of biochemistry & cell biology.

[17]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[18]  Metsada Pasmanik-Chor,et al.  Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[19]  Heba Ragaee Abdelhakam Aboelenein,et al.  Dual downregulation of microRNA 17-5p and E2F1 transcriptional factor in pediatric systemic lupus erythematosus patients , 2013, Rheumatology International.

[20]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[21]  Soma Banerjee,et al.  Hepatitis B Virus X Protein Upregulates hELG1/ ATAD5 Expression through E2F1 in Hepatocellular Carcinoma , 2016, International journal of biological sciences.

[22]  Jaewoo Kang,et al.  Literature-based condition-specific miRNA-mRNA target prediction , 2017, PloS one.

[23]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[24]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[25]  S. Jhanwar,et al.  Genomic instability and proliferation/survival pathways in RB1-deficient malignancies. , 2017, Advances in biological regulation.

[26]  Doron Lancet,et al.  MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search , 2016, Nucleic Acids Res..

[27]  Carlo M. Croce,et al.  miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response , 2015, Oncotarget.